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abstract
 
Local anesthetics are a diverse group of clinically useful compounds that act as pore blockers of both
voltage- and cyclic nucleotide–gated (CNG) ion channels. We used the local anesthetic tetracaine to probe the na-
ture of the conformational change that occurs in the pore of CNG channels during the opening allosteric transi-
tion. When applied to the intracellular side of wild-type rod CNG channels expressed in 
 
Xenopus
 
 oocytes from the
 
a 
 
subunit, the local anesthetic tetracaine exhibits state-dependent block, binding with much higher affinity to
closed states than to open states. Here we show that neutralization of a glutamic acid in the conserved 
 
P
 
 region
(E363G) eliminated this state dependence of tetracaine block. Tetracaine blocked E363G channels with the same
effectiveness at high concentrations of cGMP, when the channel spent more time open, and at low concentrations
of cGMP, when the channel spent more time closed. In addition, Ni
 
2
 
1
 
, which promotes the opening allosteric
transition, decreased the effectiveness of tetracaine block of wild-type but not E363G channels. Similar results
were obtained in a chimeric CNG channel that exhibits a more favorable opening allosteric transition. These re-
sults suggest that E363 is accessible to internal tetracaine in the closed but not the open configuration of the pore
and that the conformational change that accompanies channel opening includes a change in the conformation or
accessibility of E363.
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introduction
 
Cyclic nucleotide–gated (CNG)
 
1
 
 ion channels are key
players in visual and olfactory signal transduction path-
ways (reviewed in Lancet, 1986; Yau and Baylor, 1989;
Zufall et al., 1994). Although they are only weakly volt-
age dependent, CNG channels have regions of se-
quence similarity with voltage-gated channels (Jan and
Jan, 1990). One region of high conservation between
CNG channels and voltage-gated channels is the
 
 P 
 
re-
gion, thought to line a portion of the ion-conducting
pore. 
 
Shaker
 
 K
 
1
 
 channels that have had portions of
their
 
 P 
 
region replaced with the corresponding region
from CNG channels take on many of the permeation
properties of CNG channels (Heginbotham et al.,
1992). These chimeric channels become permeable to
Na
 
1
 
 as well as to K
 
1
 
 and become blocked by the diva-
lent cations Mg
 
2
 
1
 
 and Ca
 
2
 
1
 
. 
Like voltage-gated channels, CNG channels are thought
to possess multi-ion pores (Furman and Tanaka, 1990;
Sesti et al., 1995). The external divalent cation binding
site is thought to involve the E363 position in the 
 
P
 
 re-
gion of CNG channels (Root and MacKinnon, 1993;
Eismann et al., 1994). Neutralization of this binding
site eliminates anomalous mole-fraction dependence
(Sesti et al., 1995) and external block by protons (Root
and MacKinnon, 1994) and divalent cations (Root and
MacKinnon, 1993; Eismann et al., 1994) while still leav-
ing the channels vulnerable to internal block by diva-
lent cations. This suggests that there is a second, inter-
nal cation binding site. The specific residues that con-
tribute to this internal binding site remain unknown.
Another feature in common between voltage-gated
channels and CNG channels is block by local anesthet-
ics. Local anesthetics are a family of chemically related
compounds that have a bulky, hydrophobic end that
makes them lipid soluble and a tertiary amine group
that, in most local anesthetics, is positively charged at
pH 7. Local anesthetics are state-dependent blockers
that appear to bind preferentially to the inactivated
state of voltage-gated sodium channels (Hille, 1992).
The local anesthetic tetracaine has recently been shown
to produce a state-dependent block of rod and olfac-
tory CNG channels (Fodor et al., 1997). Tetracaine be-
comes more effective at blocking CNG channels under
conditions that permit the channels to spend more
time in closed states, such as low concentrations of
cGMP or saturating concentrations of cAMP. At saturat-
ing concentrations of cGMP, the rod CNG channel
spends more time in closed states than does the olfac-
tory CNG channel (Goulding et al., 1994; Gordon and
Zagotta, 1995
 
b
 
). Under these conditions, tetracaine is
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more effective at blocking the rod channel than the ol-
factory channel. These results suggest that tetracaine
binds to closed states of CNG channels with approxi-
mately three orders of magnitude higher affinity than
to open states. In addition, tetracaine block is voltage
dependent, becoming more effective at depolarized
voltages. The voltage dependence of tetracaine is simi-
lar to the voltage dependence observed in the related
compounds amiloride and l-
 
cis
 
-diltiazem (Haynes, 1992;
McLatchie and Matthews, 1992; McLatchie and Mat-
thews, 1994). This voltage dependence is consistent with
the hypothesis that tetracaine blocks the pore of CNG
channels. The existence of a state-dependent pore block
suggests that the inner mouth of the pore of CNG
channels undergoes a conformational change during
channel opening. In this paper, we find that a mutation
of the E363 residue within the 
 
P
 
 region disrupted tetra-
caine’s high affinity binding to the closed state. This
suggests that the conformational change within the
pore during channel opening involves movement of
the E363 residue.
 
methods
 
The methods in this paper follow those previously described
(Fodor et al., 1997). Briefly, the cDNA clone for the 
 
a
 
 subunit
(subunit 1) of the bovine rod channel was isolated, and the
amino acid sequence was identical to the published sequence
(Kaupp et al., 1989). Site-directed mutations were generated us-
ing a technique based on PCR. Oligonucleotide primers were
synthesized with the appropriate point mutations and were used
to generate insert fragments by PCR. The mutant inserts were li-
gated in place of the corresponding regions of the wild-type
channel. Verification of the mutations was confirmed by DNA se-
quencing. The splice site of the amino terminal chimera CHM15
was located at residue T162 in the rod channel or W141 in the ol-
factory channel.
Channel expression and electrophysiological recordings were
as previously described (Fodor et al., 1997). Briefly, 
 
Xenopus
 
 oocytes
were injected with cRNA coding for the appropriate channel,
incubated for 3–10 d at 16
 
8
 
C, and patch-clamped in the inside-
out configuration using 
 
z
 
500 K
 
V 
 
borosilicate pipettes. Solution
changes to the cytoplasmic side of the patch were made with an
RSC100 rapid solution changer (Molecular Kinetics, Pullman, WA).
Tetracaine and cyclic nucleotides were obtained from Sigma
Chemical Co. (St. Louis, MO). Tetracaine and cGMP were added
to a low divalent NaCl solution that contained 130 mM NaCl, 3
mM HEPES, and 200 
 
m
 
M EDTA. All solutions were adjusted to
pH 7.2 with NaOH. The pipette solution consisted of the low di-
valent NaCl solution without added tetracaine or cyclic nucle-
otides. The leak currents in the absence of cyclic nucleotides at
the corresponding voltages were subtracted from each record.
All experiments were performed at room temperature (
 
z
 
20
 
8
 
C).
Currents were filtered at 2 KHz and sampled at 20 KHz. Data
analysis was performed with the graphical analytical software Igor
(WaveMetrics, Lake Oswego, OR). Fits to the model in the text
were generated as previously described (Fodor et al., 1997).
In the absence of tetracaine, the currents at depolarized volt-
ages exhibited a small sag due to ion accumulation or depletion
as indicated by the small tail currents seen when stepping back to
0 mV (Zimmerman et al., 1988). The sag in current was generally
 
,
 
10%. The error caused by ion accumulation was therefore ig-
nored, and all currents were measured at the end of the voltage
pulse to allow channel gating and tetracaine block to reach
steady state.
Upon excision, currents recorded from the E363G mutation
tended to “run up” slowly with a time course of 
 
z
 
10–20 min. Ex-
periments performed with E363G mutants, therefore, were per-
formed approximately one half hour after the patch had been
excised. During this time, currents in the presence of 2 mM
cGMP were measured with a pulse to 
 
1
 
60 mV every 10 s. Experi-
ments were performed only when the currents measured by these
pulses did not change over a period of several minutes. At the
end of the experiments, currents in both mutant and wild-type
channels were again checked in the presence of 2 mM cGMP and
the data were not used if the current had changed by 
 
.
 
z
 
25%.
 
results
 
The E363G mutation eliminated the cGMP dependence of tet-
racaine block. 
 
cRNA coding for the 
 
a 
 
subunit of the rod
CNG channel was injected into 
 
Xenopus
 
 oocytes, from
which inside-out excised patch-clamp recordings were
obtained. Fig. 1 
 
A
 
 shows recordings made with voltage
steps from 0 to 
 
1
 
60 mV from a patch containing wild-
type rod channels in the presence of either 2 mM or 32
 
m
 
M cGMP. The top trace in each panel shows the cur-
rent in the absence of tetracaine and the bottom trace in
each panel shows the current in the presence of 10 
 
m
 
M
tetracaine. For wild-type channels, 10 
 
m
 
M tetracaine
blocked 70.6 
 
6 
 
2.5% (
 
n
 
 5 
 
14, mean 
 
6 
 
SEM) of the cur-
rent at 2 mM cGMP. At 32 
 
m
 
M cGMP, 10 
 
m
 
M tetracaine
became much more effective, blocking essentially all of
the current (Fig. 1 
 
A
 
, 
 
right
 
). 32 
 
m
 
M cGMP activated only
22.6 
 
6 
 
3.3% (
 
n
 
 5 
 
10) of the current seen at 2 mM
cGMP. Tetracaine has an affinity for closed states of
CNG channels that is approximately three orders of
magnitude higher than for open states (Fodor et al.,
1997). The greater block of 10 
 
m
 
M tetracaine at 32 
 
m
 
M
cGMP is observed because the channels spent more
time closed at 32 
 
m
 
M than at 2 mM cGMP.
We performed a similar experiment on channels in
which the glutamic acid at position E363 had been mu-
tated to a glycine, the residue normally present at a ho-
mologous position in the 
 
b 
 
subunit of the rod CNG
channel (Chen et al., 1993). Fig. 1 
 
B
 
 shows data col-
lected from a patch in which 10 
 
m
 
M
 
 
 
tetracaine had
been applied to mutant E363G channels in the pres-
ence of either high (2 mM) or low (256 
 
m
 
M) concen-
trations of cGMP. Tetracaine block at 2 mM cGMP was
less effective for E363G channels than it was for wild-
type channels. At this saturating concentration of cGMP,
10 
 
m
 
M tetracaine blocked only 35.5 
 
6
 
 3.5% (
 
n
 
 5 
 
11) of
the current in E363G channels. Furthermore, tetra-
caine did not block E363G channels more effectively as
more of the channels were closed at the lower concen-
tration of cGMP. In E363G channels, 256 
 
m
 
M cGMP ac-
tivated 46.2 
 
6 
 
0.8% (
 
n
 
 5 
 
3) of the current seen at 2
mM cGMP. Yet, despite the fact that the channels were
spending more time closed at 256 
 
m
 
M cGMP, 10 
 
m
 
M 
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tetracaine blocked only 31.9 
 
6 
 
4.3% (
 
n
 
 5 
 
3) of the cur-
rent, indistinguishable from the block observed at satu-
rating cGMP.
A simple allosteric model has previously been used
(Fodor et al., 1997) to describe the state dependence of
tetracaine block of wild-type CNG channels (Scheme 1).
In this model, K is the equilibrium constant of the ini-
tial binding of cGMP to each subunit and L is the equi-
librium constant of the allosteric transition from the
 
fully liganded closed to the fully liganded open state.
K
 
Dc
 
 is the disassociation constant of tetracaine from
closed states of the channel and K
 
Do
 
 is the disassocia-
tion constant of tetracaine from the open state of the
channel.
Fig. 1 
 
C
 
 shows the effect of 10 
 
m
 
M tetracaine on wild-
type (
 
d
 
) and E363G (
 
s
 
) channels at different concen-
trations of cGMP for a number of different patches as
measured at 
 
1
 
60 mV. Plotted on the y-axis is current in
the presence of 10 
 
m
 
M tetracaine normalized by the
current in the absence of tetracaine at the concentra-
tion of cGMP specified on the x-axis. For wild-type chan-
nels, the effectiveness of tetracaine as a blocker greatly
increased as the cGMP concentration was lowered. The
curve through the wild-type data is a fit of Scheme 1
with nearly three orders of magnitude higher binding
affinity of tetracaine to closed states (K
 
Dc
 
 
 
5 
 
240 nM)
than to the open state (K
 
Do
 
 
 
5 
 
180 
 
m
 
M). In contrast to
wild-type channels, the effectiveness of tetracaine block
did not change for E363G channels when the channels
Figure 1. Tetracaine became more effective at
low concentrations of cGMP for wild-type but not
for E363G channels. (A and B) Comparison of the
effect of 10 mM tetracaine on wild-type (A) and
E363G (B) channels. Currents are in response to
a voltage step to 160 mV from a holding potential
of 0 mV. The currents recorded in the absence of
tetracaine (top traces) are superimposed with the
currents recorded in the presence of 10 mM tetra-
caine (bottom traces). Shaded lines show the zero
current level. Leak current in the absence of
cGMP has been subtracted from all traces. (C)
The effect of 10 mM tetracaine at different con-
centrations of cGMP for wild-type rod channels
(d, n 5 4) or E363G channels (s, n 5 4). Data
pooled from a number of different patches. On
the y-axis is the current, recorded with 10 mM tet-
racaine normalized by the current recorded in
the absence of tetracaine at the concentration of
cGMP indicated on the x-axis. All currents were
measured at 160 mV. Fits to the data are from
Scheme 1 (see text) with K 5 4,500 M21, L 5 17,
KDc 5 240 nM, KDo 5 180 mM for wild-type chan-
nels and KDc 5 KDo 5 20 mM (i.e., no state depen-
dence of tetracaine block) for E363G channels.594 Tetracaine Reports a Conformational Change in Cyclic Nucleotide-gated Channels
spent more time in closed states at low cGMP concen-
trations (Fig. 1 C, s). 
One way to detect state-dependent block is to deter-
mine if the blocker produces a shift in the apparent af-
finity for cGMP. Fig. 2 compares the effect of 10 mM tet-
racaine on cGMP dose–response relations in wild-type
(Fig. 2 A) and E363G (Fig. 2 B) channels as measured
at 160 mV. The lines through the data show fits gener-
ated from the Hill equation of the form
(1)
where IMax is the current produced by saturating cGMP,
n is the Hill slope (usually z2 for these channels) and
K1/2cGMP is the concentration of cGMP that produces
half of the current seen at saturating cGMP. cGMP
dose–response curves in the absence of tetracaine (Fig.
2, d) were normalized by the current obtained at 2 mM
cGMP. For comparison, cGMP dose–response curves in
the presence of 10 mM tetracaine (Fig. 2, s) were nor-
malized by the current obtained in the presence of 2
mM cGMP and 10 mM tetracaine. In wild-type channels,
tetracaine’s state-dependent block caused the value of
K1/2cGMP to shift from 70.7 6 4.5 mM (n 5 20) in the ab-
sence of tetracaine to 246.9 6 13.8 mM (n 5 4) in the
presence of 10 mM tetracaine (Fig. 2 A). This shift in
the apparent affinity for cGMP presumably occurred
because tetracaine held the channels closed, and hence
a higher concentration of cGMP was required to drive
the channels into the open state (Fodor et al., 1997).
The E363G mutation did not, as we have seen, elimi-
nate tetracaine block of the channel, but it did elimi-
nate the shift in apparent affinity for cGMP caused by
10 mM tetracaine. The normalized cGMP dose–response
curves for E363G channels in the presence and absence
of tetracaine are essentially identical (Fig. 2 B). The
K1/2cGMP for E363G channels in the absence of tetra-
caine was 249.6 6 24.6 mM (n 5 10), very similar to the
I
IMax
--------- cGMP []
n
K 1 2 cGMP ¤
n cGMP []
n +
------------------------------------------------------ =
K 1/2cGMP in the presence of 10 mM tetracaine, 280.6 6
26.0 mM (n 5 5). The elimination of the shift in the
cGMP dose–response curve suggests that tetracaine
binding is no longer state dependent in the mutant chan-
nel,  and hence tetracaine no longer interferes with
cGMP’s ability to drive the channels into the open
state. 
Scheme 1 suggests that the fractional block seen in
Fig. 1 C in the E363G channel would occur if the closed
state affinity were 20 mM. For wild-type channels, the fit
from the model gives a closed state affinity of 240 nM.
The E363G mutation, therefore, reduced the affinity of
tetracaine for the closed state by a factor of z100. This
result is consistent with the hypothesis that tetracaine’s
high affinity binding to closed states arises from an elec-
trostatic interaction between the positively charged tet-
racaine molecule and the negatively charged glutamic
acid. Alternatively, the effects seen in the E363G muta-
tion may be due to the smaller side chain present in the
glycine residue. In either case, tetracaine becomes a
much less effective blocker of the E363G channel.
The E363G mutation eliminates Ni21 relief of tetracaine
block. E363G mutant channels have a significantly re-
duced apparent affinity for cGMP when compared with
wild-type channels (Fig. 2), consistent with the hypoth-
esis that the E363G mutation makes the opening transi-
tion less favorable. This hypothesis is in agreement with
single-channel recordings that show that at room tem-
perature and saturating concentrations of cGMP, the
E363G channel is open ,1% of the time (Sesti et al.,
1996; Bucossi et al., 1997). This raises the possibility
that the lack of state dependence observed in Fig. 1 C
could be caused by most of the E363G channels being
closed even at high concentrations of cGMP. If 99% of
the E363G channels at saturating concentrations of
cGMP were closed, then tetracaine’s affinity for these
closed channels would dominate tetracaine’s affinity
for the few open channels. If this were the case, there
could be significant differences between tetracaine’s
Figure 2. Tetracaine shifted the cGMP dose–
response curve to the right in wild-type but not
E363G channels. (A and B) cGMP dose–response
curves in the absence and presence of 10 mM tet-
racaine for a patch containing wild-type (A) or
E363G (B) channels. Currents in the absence of
tetracaine are normalized to currents obtained in
the presence of saturating (2 mM) cGMP. For
comparison, currents in the presence of 10 mM
tetracaine are normalized to currents obtained in
the presence of saturating (2 mM) cGMP 1 10
mM tetracaine. All currents were measured at 160
mV. Fits are to Eq. 1. For the wild-type rod chan-
nel in the absence of tetracaine: K1/2cGMP 5 60.5
mM, n 5 2.0. For the wild-type rod channel in the presence of 10 mM tetracaine, K1/2cGMP 5 228 mM, n 5 2.0. For the rod E363G channel
both in the presence and absence of tetracaine, K1/2cGMP 5 251 mM, n 5 1.7.595 Foder et al.
ability to block the open and closed states that we
would not detect as the remaining 1% of the channels
closed at lower cGMP concentrations.
To address this possibility, we measured tetracaine af-
finity in the presence and absence of internal Ni21.
Ni21 has been shown to drive rod channels into the
open state by making the opening transition more fa-
vorable. Ni21 significantly potentiates currents recorded
from the rod channel at low concentrations of cGMP
(Ildefonse et al., 1992; Karpen et al., 1993; Gordon and
Zagotta, 1995a) or at saturating concentrations of the
partial ligand cAMP (Gordon and Zagotta, 1995a), con-
ditions that cause the channel to spend significant peri-
ods of time in closed states. Fig. 3, top shows that, in
agreement with previous results (Gordon and Zagotta,
1995a), application of 1 mM Ni21 to wild-type channels
caused essentially no increase in current when mea-
sured at 160 mV. A significant potentiation of current
did not occur because wild-type channels at saturating
cGMP are already open most of the time, so the in-
crease in the favorability of the opening allosteric tran-
sition caused by Ni21 cannot significantly increase the
maximal current observed. Application of 10 mM Ni21
to wild-type channels actually caused currents to de-
crease to 94.5 6 2.0% (n 5 5) of the current seen in
the absence of Ni21 (data not shown). This small de-
crease in current at 10 mM Ni21 was caused by a small
amount of Ni21 block of the channels (Karpen et al.,
1993; Gordon and Zagotta, 1995a). 
In contrast to its effects on wild-type channels, Ni21
produced substantial potentiation in E363G channels
(Fig. 3, bottom). Application of 1 mM Ni21 caused cur-
rents measured at 160 mV in the presence of saturat-
ing cGMP to increase by a factor of 2.76 6 0.25 (n 5 5),
while 10 mM Ni21 caused currents to increase by a fac-
tor of 3.11 6 0.33 (n 5 4). This robust potentiation by
Ni21 confirms that the E363G mutation caused a de-
crease in the open probability and that Ni21 could in-
crease the amount of time E363G channels spend open.
To test whether the E363G channel’s low open prob-
ability could account for the apparent loss of state de-
pendence of the block by tetracaine, we measured tet-
racaine dose–response curves in the presence of satu-
rating concentrations of cGMP and 0, 1, or 10 mM
internal Ni21. Fig. 4 A shows the effect of 10 mM Ni21
on block of wild-type and E363G channels by 40 mM tet-
racaine. For wild-type channels in the absence of Ni21,
40 mM tetracaine blocked 89.8 6 1.7% (n 5 9) of the
current. In the presence of 10 mM Ni21, however, 40
mM tetracaine became much less effective, blocking
only 51.1 6 2.0% (n 5 3) of the current. Tetracaine
presumably became less effective because Ni21 increased
the already high open probability of the channel. This
small change in the open probability (e.g., from 0.96 to
0.98) is associated with a large change in the closed
probability (e.g., from 0.04 to 0.02, a twofold change).
Because tetracaine greatly prefers to bind to closed
states, it is very sensitive to these changes in the fraction
of time the channel spends closed (Fodor et al., 1997).
Fig. 4 B shows tetracaine dose–response curves mea-
sured for wild-type channels in the absence (d), or
presence of 1 (j) or 10 (m) mM Ni21. As the Ni21 con-
Figure 3. Ni21 substantially in-
creases the currents produced by
saturating (4 mM) cGMP in
E363G but not in wild-type chan-
nels. Currents are in response to
families of voltage steps from a
holding potential of 0 to between
280 and 180 mV in increments
of 120 mV. Leak currents in the
absence of cGMP have been sub-
tracted.596 Tetracaine Reports a Conformational Change in Cyclic Nucleotide-gated Channels
centration increased, tetracaine became a less effective
blocker and the tetracaine dose–response curve shifted
to the right. In contrast, Ni21 potentiation did not af-
fect tetracaine apparent affinity for the E363G channel.
Fig. 4 C shows that tetracaine dose–response curves for
the E363G channel in the presence of saturating (2
mM) cGMP and 0 (d), 1 (j), and 10 (m) mM Ni21
were essentially identical. This is true despite the fact
that Ni21 robustly potentiates the E363G channels
(Fig. 3).
The fits to the data in Fig. 4, B and C are the Hill
equation in the form:
(2)
where I is the current in the absence of tetracaine, ITet
is the current in the presence of tetracaine, n is the Hill
slope, and K1/2Tet is the apparent affinity for tetracaine.
Fig. 4 D shows values of K1/2Tet derived from fits of this
equation to tetracaine dose–response curves in the ab-
sence and presence of Ni21. In wild-type channels, in-
creasing concentrations of Ni21 made tetracaine less ef-
fective, increasing K1/2Tet. In contrast, tetracaine had es-
sentially the same apparent affinity for the E363G channel
at 0, 1, and 10 mM Ni21. These data suggest that the loss
of cGMP dependence of tetracaine block seen for E363G
channels in Fig. 1 is the result of a true loss of state de-
pendence of tetracaine binding and not due merely to
the lower open probability of mutant channels. 
In addition to shifting the apparent affinity for tetra-
caine, the E363G mutation also shifted the Hill slope
from 1 (Fodor et al., 1997) for wild-type channels to
1.20 6 0.21 (n 5 6) for E363G channels. While this is
not a large difference, and was not enough to signifi-
cantly affect the values of K1/2Tet derived for E363G,
most tetracaine dose–response curves for E363G were
not well fit with a Hill slope of 1. We do not understand
what caused this difference between wild-type and
E363G channels.
Chimeric E363G channels with the olfactory NH2 terminus
also lack state-dependent block by tetracaine.  Application of
cytoplasmic Ni21 is one way to increase the open proba-
bility of E363G channels. Another way is to substitute
the NH2 terminus of the olfactory channel into the rod
channel (Goulding et al., 1994; Gordon and Zagotta,
1995b). The chimeric channel called CHM15, which has
the olfactory NH2 terminus substituted into the wild-
type rod channel, has values for the equilibrium con-
stant of the opening allosteric transition (L in Scheme
1) z10-fold higher than wild-type rod channels (Gor-
don and Zagotta, 1995b). We reasoned that at saturat-
ing concentrations of cGMP the CHM15 channel with
the E363G mutation would be open a higher fraction
of the time than the rod channel with the E363G muta-
tion. The improved open probability of CHM15-E363G
ITet
I
--------
K 1 2 Tet ¤
n
K1 2 Tet ¤
n Tet []
n +
------------------------------------------ =
channels would allow a better measurement of the ef-
fectiveness of tetracaine block on open channels with
the E363G mutation. This in turn would further allow
us to exclude the possibility that the lack of state de-
Figure 4. The E363G mutation eliminated Ni21 relief of tetra-
caine block. (A) Block of wild-type and E363G channels in the ab-
sence and presence of Ni21. Currents are in response to a voltage
step to 160 mV from a holding potential of 0 mV for four separate
patches. In each panel, the top trace shows current in the absence
of tetracaine and the bottom trace shows current in the presence
of 40 mM tetracaine. The shaded line represents the zero current
level. (B) Dose–response curves for tetracaine from three separate
patches containing wild-type rod channels in the presence of 0
(d), 1 (j), and 10 (m) mM Ni21. All currents were measured at
160 mV. All currents were recorded in the presence of saturating
(2 mM) cGMP and normalized by currents recorded in the ab-
sence of tetracaine. Fits are to Eq. 2. For 0 mM Ni21: K1/2Tet 5 3.4
mM, n 5 1.0; for 1 mM Ni21: K1/2Tet 5 13.3 mM, n 5 1.1; and for 10
mM Ni21: K1/2Tet 5 37.7 mM, n 5 1.0. (C) Dose–response curves for
tetracaine for three separate patches recorded from E363G chan-
nels in the presence of 0 (d), 1 (j), and 10 (m) mM Ni21. The fit
is to Eq. 2 with K1/2Tet 5 15.19 mM, n 5 1.6. (D) Box plots showing
range of tetracaine apparent affinities for wild-type and E363G
channels in 0, 1, and 10 mM Ni21. The line in the middle of the
boxes shows the median. The top and bottom edges of the boxes
show the 25th and 75th percentiles of the data. The whiskers com-
ing out of some of the boxes show the 5th and 95th percentiles.
Circles represent outliers.597 Foder et al.
pendence observed in E363G channels was due to the
low open probability of these channels, causing us to
miss tetracaine’s behavior on the few open channels.
As expected, substitution of the olfactory channel’s
NH2 terminus shifted the apparent affinity for cGMP
from 249.6 6 24.6 mM (n 5 10) in the rod channel with
the E363G mutation to 119.2 6 9.1 mM (n 5 5) in the
CHM15-E363G channel. This confirms that the pres-
ence of the olfactory NH2 terminus produces E363G
channels in which the opening allosteric transition is
more favorable.
Fig. 5 compares cGMP dose–response curves in the
absence (d) and presence (s) of 40 mM tetracaine for
CHM15 (Fig. 5 A) and CHM15-E363G (Fig. 5 B). As was
the case for wild-type channels (Fig. 2 A), application of
tetracaine to CHM15 caused a substantial shift in the
values for K1/2cGMP from 20.6 6 2.1 mM (n 5 10) in the
absence to 125.4 6 14.4 mM (n 5 5) in the presence of
40  mM tetracaine (Fig. 5 A). In the CHM15-E363G
channel, this shift in the cGMP dose–response curve
was eliminated (Fig. 5 B). The K1/2cGMP for E363G chan-
nels in the presence of 40 mM tetracaine, 116.6 6 1.0
mM (n 5 3), was essentially identical to the K1/2cGMP in
the absence of tetracaine, 119.2 6 9.1 mM (n 5 5).
Fig. 6 A compares 40 mM tetracaine block at a high (2
mM) and low (32 mM) concentration of cGMP for a
patch containing CHM15 channels. As was the case for
wild-type rod channels, lowering cGMP concentration
caused tetracaine to become much more effective. Fig.
6 B shows a similar experiment comparing 40 mM tetra-
caine block at a high (2 mM) and low (128 mM) con-
centration of cGMP for a patch containing CHM15-
E363G channels. As was the case for E363G channels,
tetracaine block did not become more effective as more
of the CHM15-E363G channels were closed at the lower
cGMP concentration. Fig. 6 C compares fractional block
of 40 mM tetracaine measured at 160 mV for CHM15
and CHM15-E363G channels from a number of patches
Figure 5. Tetracaine shifted
the cGMP dose–response curve
to the right in CHM15 but not
CHM15-E363G channels. (A and
B) cGMP dose–response curves
in the absence and presence of
40  mM tetracaine for a patch con-
taining CHM15 (A) or CHM15-
E363G (B) channels. Currents
in the absence of tetracaine are
normalized by currents ob-
tained in the presence of satu-
rating (2 mM) cGMP. For com-
parison, currents in the presence
of 40 mM tetracaine are normal-
ized by currents obtained in the
presence of saturating (2 mM) cGMP 1 40 mM tetracaine. All currents were measured at 160 mV. Fits are to Eq. 1. For the CHM15 channel
in the absence of tetracaine, K1/2cGMP 5 15.6 mM, n 5 2.1. For the CHM15 channel in the presence of 40 mM tetracaine, K1/2cGMP 5 108.7
mM, n 5 2.1. And for the CHM15-E363G channel both in the presence and absence of tetracaine, K1/2cGMP 5 117.0 mM, n 5 2.0.
Figure 6. Tetracaine becomes more effective at low concentra-
tions of cGMP for CHM15 but not for CHM15-E363G channels. (A
and B) Comparison of the effect of 40 mM tetracaine on CHM15
(A) and CHM15-E363G (B) channels. Currents are in response to
a voltage step to 160 mV from a holding potential of 0 mV. The
currents recorded in the absence of tetracaine (top traces) are su-
perimposed with the currents recorded in the presence of 40 mM
tetracaine (bottom traces). Shaded lines show the zero current level.
Leak current in the absence of cGMP has been subtracted from all
traces. (C) The effect of 40 mM tetracaine at different concentra-
tions of cGMP for CHM15 (h, n 5 5) or CHM15-E363G (d, n 5
4) channels. Data were pooled from a number of different patches.
On the y-axis is the current, recorded with 40 mM tetracaine nor-
malized by the current recorded in the absence of tetracaine at the
concentration of cGMP indicated on the x-axis. All currents were
measured at 160 mV. Fits to the data are from Scheme 1, with
K 5 4,500 M21, L 5 300, KDc 5 200 nM, KDo 5 200 mM for CHM15
channels and KDc 5 KDo 5 25 mM (i.e., no state dependence of tet-
racaine block) for CHM15-E363G channels.598 Tetracaine Reports a Conformational Change in Cyclic Nucleotide-gated Channels
over a range of cGMP concentrations. As was the case
for wild-type channels (Fig. 1), decreasing cGMP concen-
tration caused tetracaine block to increase for CHM15
channels, and this relationship was well described by
Scheme 1. Lowering cGMP concentration, however,
did not change the degree of tetracaine block of CHM15-
E363G channels.
The CHM15-E363G channel contains H420 from the
rod channel, which allows for Ni21 potentiation (Gor-
don and Zagotta, 1995b). We exploited the presence of
this potentiating histidine to drive these channels fur-
ther into the open state by applying Ni21. Application
of 10 mM Ni21 confirmed that the CHM15-E363G chan-
nel (Fig. 7) spends considerably more time in the open
state than does the E363G channel with the rod NH2
terminus. When measured at 160 mV, CHM15-E363G
currents in the presence of Ni21 were identical to those
measured in the absence of Ni21 (INi21/I 5 1.0 6 0.1,
n 5 3). This is in contrast to the E363G mutation in the
rod channel, where application of Ni21 caused the cur-
rent to increase (Fig. 3). As was the case for wild-type
channels, application of 10 mM Ni21 caused a slight
block of the CHM15 channel (INi21/I 5 0.94 6 0.013,
n 5 3).
We measured tetracaine dose–response curves for
CHM15 and CHM15-E363G channels in the presence
of saturating concentrations of cGMP and 10 mM inter-
nal Ni21. Fig. 8 A shows the effects of 10 mM Ni21 on 40
mM tetracaine block of currents in CHM15 and CHM15-
E363G channels. Ni21 decreased tetracaine’s effective-
ness on CHM15 channels, but not CHM15-E363G chan-
nels. Application of 10 mM Ni21 to the CHM15 channel
shifted tetracaine’s dose–response curve to the right
(Fig. 8 B) while not changing tetracaine’s dose–response
curve for the CHM15-E363G channel (Fig. 8 C). Fig. 8
D shows a box plot comparing values of K1/2Tet mea-
sured at 160 mV for CHM15 and CHM15-E363G chan-
nels in the presence and absence of Ni21. Application
of 10 mM Ni21 changed the apparent affinity of tetra-
caine for CHM15. For CHM15-E363G, however, the ap-
parent affinity of tetracaine in the presence of 10 mM
Figure 7. The effects of Ni21 on CHM15 and CHM15-E363G.
Currents are in response to families of voltage steps from a holding
potential of 0 to between 280 and 180 mV in increments of 120
mV. Leak currents in the absence of cGMP have been subtracted.
Figure 8. The E363G mutation in CHM15 eliminated Ni21 relief
of tetracaine block. (A) Block of CHM15 and CHM15-E363G
channels in the absence and presence of Ni21. Currents are in re-
sponse to a voltage step to 160 mV from a holding potential of 0
mV for four separate patches. In each panel, the top trace shows
current in the absence of tetracaine and the bottom trace shows
current in the presence of 40 mM tetracaine. The shaded line rep-
resents the zero current level. (B) Dose–response curves for tetra-
caine from two separate patches containing CHM15 channels in
the presence of 0 (d) or 10 (m) mM Ni21. All currents were mea-
sured at 160 mV. All currents were recorded in the presence of
saturating (2 mM) cGMP and normalized by currents recorded in
the absence of tetracaine. Fits are to Eq. 2. For 0 mM Ni21: K1/2Tet 5
26.5 mM, n 5 1.0; for 10 mM Ni21: K1/2Tet 5 59.4 mM, n 5 1.0. (C)
Dose–response curves for tetracaine for two separate patches re-
corded from CHM15-E363G channels in the presence of 0 (d) or
10 (m) mM Ni21. The fit is to Eq. 2 with K1/2Tet 5 31.0 mM, n 5 1.3.
(D) Box plot showing range of tetracaine-apparent affinities for
CHM15 and CHM15-E363G channels in 0 and 10 mM Ni21. The
line in the middle of the boxes shows the median. The top and
bottom edges of the boxes show the 25th and 75th percentiles of
the data. The whiskers coming out of some of the boxes show the
5th and 95th percentiles.599 Foder et al.
Ni21 was essentially indistinguishable from the appar-
ent affinity in the absence of Ni21.
Taken together, these results show that even in the
wider range of open probabilities obtained in the pres-
ence of the olfactory amino terminus, we were unable
to detect any state dependence to tetracaine block in
the presence of the E363G mutation. These results
strongly support our hypothesis that the state depen-
dence of tetracaine binding arises from a conforma-
tional change that occurs at the E363 residue.
discussion
Tetracaine block of wild-type rod and olfactory CNG
channels displays strong state dependence, with the af-
finity for closed channels approximately three orders
of magnitude higher than the affinity for open chan-
nels (Fodor et al., 1997). In wild-type channels, tetra-
caine became more effective as channels spent more
time closed at lower cGMP concentrations and less ef-
fective as channels were driven into open states with
high concentrations of cGMP and internal Ni21. We
have shown that the pore mutation E363G eliminated
the state dependence of tetracaine block. Tetracaine
was equally effective at blocking E363G channels at low
concentrations of cGMP or at high concentrations of
cGMP and internal Ni21. Similar results were obtained
on channels in which the olfactory NH2 terminus had
been introduced into the rod channel. These chimeric
channels had a higher value for the equilibrium con-
stant of the opening allosteric transition than their rod
counterparts. This allowed tetracaine block to be stud-
ied over a broader range of open probabilities.
A model that is consistent with our results is shown in
Fig. 9. This model envisions strong, stabilizing electro-
static interactions between tetracaine’s positive charge
and the negative charge of E363 in the closed state of the
wild-type channel. This electrostatic interaction confers
tetracaine’s high affinity binding to the closed states of
CNG channels. The conformational change in the pore
that accompanies channel opening moves E363 away
from tetracaine’s positive charge. This movement of
E363 during channel opening significantly weakens tetra-
caine’s ability to bind to the open pore. Alternatively, it is
possible that the opening conformational change might
prevent access of tetracaine to E363. The state depen-
dence of tetracaine block observed in wild-type channels,
therefore, arises from tetracaine’s ability to interact with
E363 in the closed, but not the open, conformations of
the pore. Neutralization of this charge via the E363G mu-
tation specifically eliminates tetracaine’s high affinity
binding to closed states of the channel and hence elimi-
nates the state dependence of tetracaine block.
The model in Fig. 9 argues that in the closed confor-
mation of the pore, E363G is accessible to internally ap-
plied tetracaine. The E363 residue has previously been
shown to be part of the site that binds externally ap-
plied monovalent and divalent cations (Root and MacKin-
non, 1993; Eismann et al., 1994; Sesti et al., 1995). Mu-
tations at the E363 position, however, still leave the
channel vulnerable to block by internal divalent cat-
ions, suggesting that there is a second, internal cation
binding site. The specific residues that contribute to
this internal binding site remain unknown. Sun et al.
(1996) used cysteine-scanning mutagenesis to examine
which regions of the pore were accessible to internally
and externally applied cysteine-modifying reagents. The
E363C mutation did not produce functional channels,
but the residues immediately adjacent to E363 were
both accessible from both the inside and the outside of
the channel. This suggests that E363 is in a region of
the pore that can be accessed from both sides of the
membrane. The state dependence of tetracaine bind-
ing suggests that E363 may be more accessible from the
inside when the channel is closed.
Mutations at the E363 position produce in the chan-
nel nonconducting states that are not included in our
simple model of tetracaine block (Bucossi et al., 1996).
The existence of these nonconducting states, however,
is unlikely to explain the phenomena that we have ob-
served in this paper. If these states had a high affinity
for tetracaine, then tetracaine should have become
more effective for the E363G mutation than for wild-
type channels. Clearly, this did not happen. If these
states had a very low affinity for tetracaine, and the vast
majority of the channels in a patch were in this state,
then it is possible that the state dependence of the re-
maining channels would be overwhelmed by the non-
conducting state. For the state dependence of the re-
maining channels to be undetectable, however, we esti-
mate that 95–98% of the channels in a patch would
Figure 9. State-dependent tetracaine block in wild-type chan-
nels. See text.600 Tetracaine Reports a Conformational Change in Cyclic Nucleotide-gated Channels
have to be in this nonconducting state. This seems un-
likely, especially in the CHM15 background where ro-
bust currents were common.
The negative charge at E363 is well conserved through-
out the superfamily of voltage-gated channels (Hegin-
botham et al., 1992). Local anesthetics block many
members of this superfamily with sometimes quite com-
plex state dependence. This raises the possibility that
the interaction described in this paper may influence
the state dependence of a wide range of drug–receptor
interactions. Future research using different combina-
tions of channels and drugs may shed light on the per-
vasiveness of this interaction and provide a higher reso-
lution picture of how E363 moves in relationship to
other residues in the pore during the opening of CNG
and voltage-gated channels.
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